Table 2.

The types of tumors in 75 anti-LM332-type MMP patients.

Tumor Type	Number of Patients (%)	References
Lung	17 (22.67%)	[11,12,22,24,26,31,32,63,66,67,68]
Gastric	13 (17.33%)	[22,24,27,39,66,69,70,71]
Uterine	10 (13.33%)	[22,24,66,69,72,73]
Pancreatic	6 (8.00%)	[22,40,74,75]
Colon	6 (8.00%)	[22,24,66,72]
Ovary	5 (6.67%)	[18,22,76,77,78]
Prostate	4 (5.33%)	[20,22,79]
Thyroid	4 (5.33%)	[22,65]
B-cell lymphoma	3 (4.00%)	[22,80]
Leukemia	3 (4.00%)	[22,70]
Liver	3 (4.00%)	[22,39,81]
Kidney	3 (4.00%)	[22,65,82]
Adenocarcinoma	2 (2.67%)	[22,83]
Tongue	2 (2.67%)	[79]
Pharynx	1 (1.33%)	[20,22,65]
Breast	1 (1.33%)	[22]
Cutaneous lymphoma	1 (1.33%)	[62]
Total	75 (100%)	/